De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation

Conditions

De Novo Autoimmune Hepatitis

What is the purpose of this trial?

The purpose of this study is to provide insights into the cause, development and effects of de novo autoimmune hepatitis so that prevention and treatment strategies can be developed in order to reduce post-liver transplant morbidity, the frequency of liver allograft loss and the need for re-transplantation.


Participation Guidelines

Age:
3 Months - 50 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University School of Medicine
Dates:
11/06/2013
Last Updated:
Study HIC#:
1302011561